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Background: Major depressive disorder (MDD) is associated with increased heart rate
and reductions in its variability (heart rate variability, HRV) – markers of future morbidity
and mortality – yet prior studies have reported contradictory effects.We hypothesized that
increases in heart rate and reductions in HRV would be more robust in melancholia relative
to controls, than in patients with non-melancholia.
Methods: A total of 72 patients with a primary diagnosis of MDD (age M : 36.26, SE: 1.34;
42 females) and 94 controls (age M : 35.69, SE: 1.16; 52 females) were included in this
study. Heart rate and measures of its variability (HRV) were calculated from two 2-min
electrocardiogram recordings during resting state. Propensity score matching controlled
imbalance on potential confounds between patients with melancholia (n = 40) and non-
melancholia (n = 32) including age, gender, disorder severity, and comorbid anxiety
disorders.
Results: MDD patients with melancholia displayed signiﬁcantly increased heart rate and
lower resting-state HRV (including the square root of the mean squared differences
between successive N–N intervals, the absolute power of high frequency and standard
deviation of the Poincaré plot perpendicular to the line of identity measures of HRV) relative
to controls, ﬁndings associated with a moderate effect size (Cohens d ’s = 0.56–0.58).
Patients with melancholia also displayed an increased heart rate relative to those with non-
melancholia (Cohen’s d = 0.20).
Conclusion: MDD patients with melancholia – but not non-melancholia – display robust
increases in heart rate and decreases in HRV. These ﬁndings may underpin a variety of
behavioral impairments in patientswithmelancholia including somatic symptoms, cognitive
impairment, reduced responsiveness to the environment, and over the longer-term,
morbidity and mortality.
Keywords: melancholia, non-melancholia, electrocardiogram, ECG, heart rate, heart rate variability, HRV, resting
state
INTRODUCTION
Unfortunately, most researchers in psychiatry and psychology express
little interest in the mapping of autonomic regulation as a “vulnerabil-
ity”dimension for various disorders andbehavioral problems, although
visceral features are often symptoms of the disorders they are treating.
–Porges (2011)
Major depressive disorder (MDD) is associated with reduced
resting-state heart rate variability (HRV; Kemp et al., 2010, 2012;
Brunoni et al., 2013; see Kemp and Quintana, 2013 for review),
and these reductions are inversely associated with disorder sever-
ity (Kemp et al., 2010). Heart rate and its variability (HRV) are
determined by a variety of physiological factors, although the
most prominent of these is the autonomic system. A high level
of parasympathetic (vagal) function is both desirable and beneﬁ-
cial as it reﬂects the capacity for an individual to respond, adapt
and regulate responses when required. One can only imagine the
consequences of buildings in Tokyo not being sufﬁciently ﬂex-
ible to withstand an earthquake. The ability to adapt quickly
to change in the environment requires ﬂexibility. Researchers
(Kashdan and Rottenberg, 2010) have argued that a fundamen-
tal component of health is psychological ﬂexibility and have
suggested that HRV may provide the psychophysiological foun-
dation for such ﬂexibility (Friedman and Thayer, 1998; Kashdan
and Rottenberg, 2010). By contrast, chronic reductions in HRV
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are associated with psychophysiological rigidity, dysregulation of
a variety of allostatic systems, and increased risk for morbid-
ity and mortality (see Kemp and Quintana, 2013 for review).
The goal of the present paper is to determine whether spe-
ciﬁc subtypes of depression display more robust alterations in
heart rate and commonly reported measures of HRV relative to
controls.
In the resting state, the heart is under tonic inhibitory control
by the vagus, yet measures of HRV are a more speciﬁc marker of
vagal function than heart rate (Saul, 1990; Reyes Del Paso et al.,
2013). That said, different measures of HRV provide informa-
tion on different physiological control mechanisms (Reyes Del
Paso et al., 2013). For instance, high frequency oscillations (0.15–
0.4 Hz) relate to respiratory inﬂuences, while LF oscillations
(0.04–0.15 Hz) reﬂect mechanisms relating to blood pressure con-
trol such as the baroreﬂex (Reyes Del Paso et al., 2013; see also
Krygier et al., 2013).
Reduced HRV was ﬁrst reported in depressed patients more
than two-decades ago (Carney et al., 1988), and more recently,
has been shown to predict adverse cardiovascular events over a
follow-up period of 3–15 years (Hillebrand et al., 2013), high-
lighting the importance of continued research in this area.
However, not all studies (Licht et al., 2008) – including our own
(Kemp et al., 2014) – have reported reduced HRV in depressed
patients highlighting the complexity of this issue. Recent debate
has focused on whether the mood and anxiety disorders, or
their treatments are associated with reductions in vagal func-
tion (Licht et al., 2011; Brunoni et al., 2012). Increases in heart
rate are usually associated with decreases in HRV, and antide-
pressant medications clearly adversely affect heart rate and
HRV (Licht et al., 2010; Kemp et al., 2014), yet uncertainty
remains over whether unmedicated depressed patients display
alterations in these psychophysiological markers (Kemp, 2011,
2012; Kemp et al., 2011, 2014; Licht et al., 2011; Brunoni et al.,
2012).
One potential explanation for the contradictory ﬁndings is that
distinct subtypes (e.g., melancholia; Gold and Chrousos, 2002;
Malhi et al., 2005)may displaymore robust alterations in heart rate
and HRV, yet studies are yet to determine whether this is the case.
Melancholia is characterized by an over-active stress response, a
loss of responsiveness to the environment, somatic symptoms (e.g.,
insomnia, loss of appetite), and worse depression in the morning
(Gold andChrousos, 2002). In addition, patientswithmelancholia
display greater cognitive impairment relative to thosewithout such
features (Quinn et al., 2012a). There are several reasons to expect
that HRV will be reduced in depression generally, and that these
effects will be greatest in those patients with melancholic depres-
sion. These include the presence of somatic symptoms, cognitive
impairment, increased disorder severity, and reduced responsive-
ness to the environment; all symptoms that have been previously
associated with HRV reductions.
Firstly, somatic depressive symptoms appear to be strongly
associated with reduced HRV, at least in patients with stable coro-
nary heart disease (de Jonge et al., 2007). Secondly, there is a body
of evidence linking cognitive function and executive function in
particular to HRV (see Thayer et al., 2009 for review; Kemp et al.,
unpublished ﬁndings). Participants with high HRV have been
shown to perform better on executive function tasks relative to
those with low HRV. These effects have been observed in a vari-
ety of populations including young men (Hansen et al., 2004) and
older women (Kim et al., 2006), while performance on cognitive
tasks has been shown to improve with aerobic exercise (Hansen
et al., 2004; Albinet et al., 2010). Thirdly, melancholic depression
is generally a more severe form of depression – although differ-
ences between melancholia and non-melancholia are more than
simple variation on severity (Quinn et al., 2012b) – and reduc-
tions in HRV are correlated with increasing depression severity
(Kemp et al., 2010). Fourthly, the capacity to adequately respond
to change in the environment requires ﬂexibility – melancholic
patients are less responsive – and HRV may provide the psy-
chophysiological foundation for such ﬂexibility (Thayer and Lane,
2000; Kashdan and Rottenberg, 2010). Finally, it is notable
that stimulation of the left vagus nerve is a promising, alterna-
tive treatment for treatment resistant depression (Mayberg et al.,
2006), further highlighting a role for impaired vagal function in
MDD.
We have reported reductions in MDD patients across time-,
frequency- and non-linear domain measures of HRV (Kemp et al.,
2012; see also Brunoni et al., 2013), ﬁndings associated with a
small-to-moderate effect size, replicating ﬁndings we reported in
an earlier meta-analysis (Kemp et al., 2010). One of our previ-
ous studies (Kemp et al., 2012) further highlighted that reductions
in HRV were greatest in MDD patients with comorbid general-
ized anxiety disorder, ﬁndings associated with a large effect size.
Conﬁrming these ﬁndings, we recently reported, in an indepen-
dent Brazilian sample, that only those with generalized anxiety
disorder display robust, though small, increases in heart rate and
decreases inHRVafter controlling for confounding variables using
propensity scores (Kemp et al., 2014), a novel approach that allows
for more appropriate control of confounders, and a technique
we employ in the present study. Here we explore the impact
of two major subtypes of depression – melancholia and non-
melancholia – relative to controls, hypothesizing that patients with
melancholic depression rather than non-melancholic depression
will display robust decreases in HRV, relative to healthy controls,
after controlling for major confounding variables including dis-
order severity (Kemp et al., 2010) and comorbid anxiety (Kemp
et al., 2012; Alvares et al., 2013; Chalmers et al., 2014). Here we
report on a variety of HRV measures to examine the which ﬁnd-
ings are robust across different measures. On the basis of parallel
lines of evidence highlighting a major role for high heart rate in
future morbidity and mortality (Fox et al., 2007; Lemogne et al.,
2011; Åberg et al., 2014), we also examined the impact of depres-
sion on heart rate, expecting robust increases in heart rate in
melancholia.
MATERIALS AND METHODS
PARTICIPANTS
A total of 72 patients with a primary diagnosis of MDD and
94 age- and sex-matched controls were included in this study.
Participants in this study were recruited from the community as
part of case-control study conducted in 2006 and 2007 (Kemp
et al., 2012). Exclusion criteria included a history of brain injury
(causing loss of consciousness for 10 min or more), neurological
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disorder, other serious medical condition, or substance abuse or
dependence for>1 year. All participants were medication free for
at least ﬁve half-lives. Our study was approved by the University
of Sydney, Sydney West Area Health Service, University of Ade-
laide and Flinders University human research ethics committees,
and written informed consent was obtained from participants in
accordance with National Health and Medical Research Council
guidelines.
PROCEDURES
Depressedparticipantswere diagnosedwithMDDand categorized
with or without melancholic symptoms by trained and supervised
research ofﬁcers using the Mini International Neuropsychological
Interview (MINI; Sheehan et al., 1998), a structured psychiatric
interviewbasedon theDiagnostic and StatisticalManual of Mental
Disorders, FourthEdition (DSM-IV) criteria. Control participants
were excluded if they self-reported a history or presence of psychi-
atric illness; they were also screened using the MINI. Depression
severity was assessed using the 17-item structured interview guide
for the Hamilton Depression Rating Scale (SIGH-D; Hamilton,
1960; Williams, 1988) and psychomotor disturbance was mea-
sured by the CORE assessment of psychomotor change (CORE;
Hickie, 1996). The self-report, Depression, Anxiety and Stress
Scale (DASS; Lovibond and Lovibond, 1995) was completed by
participants at the completion of the clinical interview. The DASS
depression subscale is compatible with DSM-IV criteria of mood
disorders, the Anxiety scale, with symptom criteria of panic disor-
der and PTSD, and the Stress scale, with a diagnosis of generalized
anxiety disorder.
Participants were seated in a sound and light controlled room
at 24◦C and two 2-min electrocardiogram (ECG) recordings were
collected during resting state. The ECG recording disc was posi-
tioned on the inside of the left wrist, positioned at the radial
pulse, relative to a common ground and referenced to two sites:
Erbs point (located two thirds distant from midline on the clav-
icle) and C7 (the seventh Cervical vertebra; most pronounced
transverse process). Both reference sites are positioned directly
above bone and serve as relatively muscle-free references. Record-
ings were made under these conditions as part of a standardized,
psychophysiological recording protocol (Gordon et al., 2005).
Data was sampled at 500 Hz, with 22-bit resolution digitization
using a Compumedics Neuroscan Nuamps ampliﬁer and SCAN
software, version 4.3. ECG was analyzed using custom-developed
software to perform semi-automated pre-processing to remove
noise from the ECG, allowing for the identiﬁcation of the R-peaks
based on established methods (Pan and Tompkins, 1985). The
cleaned, N-N time-series for each participant was then imported
into Kubios (version 2.0, 2008, Biosignal Analysis and Medical
Imaging Group, University of Kupio, Finland, MATLAB) from
which measures of heart rate and HRV were calculated based
on established guidelines (Electrophysiology TFotESoCtNASoP,
1996).
HEART RATE MEASURES
Heart rate and its variability during the resting-state are under
tonic inhibitory control by the parasympathetic (vagal) nervous
system (Thayer et al., 2009). It is in this regard that we refer to
resting-state heart rate and HRV as surrogate measures of vagally
mediated cardiac activity, although HRV measures are more pure
(Saul, 1990), yet complex (Picard et al., 2009), indicators of vagal
activity. HRVmeasures comprised time-domain estimates, includ-
ing the standard deviation of N–N intervals (SDNN) and the
square root of the mean squared differences between successive
N–N intervals (RMSSD). SDNN is a commonly reported time-
domain measure reﬂecting all the cyclic components responsible
for variability in a recording (Electrophysiology TFotESoCtNA-
SoP, 1996). RMSSD is a stable, time-domain index less affected
by changes in breathing frequency (Penttilä et al., 2001). We
also examined frequency-based estimates using the FFT method
including the absolute power of high frequency (HF, 0.15–0.4 Hz)
and low frequency (LF, 0.04–0.15 Hz). HF relates to respira-
tory inﬂuences, while LF provides information about baroreﬂex
function (Goldstein et al., 2011). The standard deviation of the
Poincaré plot perpendicular to the line of identity (PCSD1), a
non-linear measure of HRV, was also calculated. We have pre-
viously reported that non-linear domain measures of HRV may
be more sensitive to group differences (Kemp et al., 2010). Heart
rate displays complex non-linear dynamic behavior, rather than
regular, periodic oscillation (Billman, 2011), and the PCSD1 is
a commonly reported, non-linear measure of short-term vari-
ability mainly caused by respiratory sinus arrhythmia (Tarvainen
and Niskanen, 2008). All HRV measures were log transformed to
normality.
DATA PROCESSING AND STATISTICAL ANALYSIS
All statistical analyses were performed using IBM SPSS Statistics,
Version 21 with SPSS R Essentials plug-in and R statistics version
2.14.2. To avoid bias resulting from imbalance on disorder severity
and comorbid anxiety – major confounding variables when seek-
ing to compare patients with melancholia and non-melancholia –
we conducted propensity score matching (PSM) using a custom
designed plugin for IBM SPSS Statistics (Thoemmes, 2012). PSM
involves producing a score (on the basis of entered covariates)
for each participant that relates to the probability that the sub-
ject belongs to the melancholic versus non-melancholic grouping,
and then matching patients in each grouping on this propensity
score. If two participants have the same propensity score, then
they are equally likely to have come from the same distribution
(i.e., patient grouping). Therefore, selecting patients with non-
melancholia that have the same propensity scores to those with
melancholia, we avoid any bias resulting from an imbalance on
covariates. The PSM procedure uses logistic regression to produce
the propensity score, in which patient grouping is used as the out-
come variable and selected covariates, as predictors. Covariates
entered into PSM analysis included age, gender, depression, anx-
iety and stress DASS scores, SIGH-D, and MINI anxiety disorder
status (yes, no). Cases with the closest score were then matched
using a simple 1:1 nearest neighbor matching routine based on
a ‘greedy’ matching algorithm. Balance statistics and associated
graphs were inspected to conﬁrm adequacy of the match.
As PSM requires a complete dataset without missing data, we
ﬁrst ran multiple imputation (MI) analysis (Schafer, 1999) in
IBM SPSS Statistics to replace missing values using the automatic
method. While a common approach to dealing with missing data
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is deleting observations with missing values, and analyzing only
those participants with a complete dataset, this listwise deletion
approach is problematic for at least two reasons (Barzi and Wood-
ward, 2004; van Ginkel and Kroonenberg, 2014). Firstly, it wastes
data and reduces the power of analysis to determine an effect.
Secondly, it may also produce biased estimates when loss of par-
ticipants is systematic and not random. By contrast, MI yields
estimates with good statistical properties. It uses all available data,
makes less stringent assumptions about ‘missingness’ and pools
plausible complete versions of an incomplete dataset into one
analysis taking into account additional uncertainty due to missing
data.
Data was missing for the following variables: depression
(melancholia: 27.5%; non-melancholia: 37.5%), anxiety (melan-
cholia: 22.5%; non-melancholia: 37.5%), and stress (melancholia:
22.5%; non-melancholia: 37.5%) from the DASS measure, MINI
anxiety disorder status (yes, no; melancholia: no missing data;
non-melancholia: 6.3%), and CORE total (melancholia: no miss-
ing data; non-melancholia: 3.1%) as predictors. MI procedures
are appropriate for data in which up to 60% of values are miss-
ing (Barzi and Woodward, 2004). As recommended by others
(Marshall et al., 2009), the imputationmodel used formissingdata
contained all variables to be subsequently analyzed including out-
come variables (melancholic status in PSM, and heart rate and
its variability in ﬁnal analysis), variables to predict the missing
data, and those variables to be imputed. Variables entered into
MI analysis included: participant grouping, heart rate and HRV,
depression, anxiety and stress from the DASS questionnaire, age,
gender, SIGH-D, MINI anxiety disorder status and CORE total
score.
Multiple imputation analysis produced 20 datasets relating to
72 MDD patients and PSM analysis was run on each of these
datasets to obtain patients matched on propensity scores. The
data for controls were then merged into each of the 20 datasets
after which analyses were conducted on each dataset to exam-
ine group differences (MEL vs. NMEL vs. CTRL) on heart rate
and HRV. As recommended previously (Hill, 2004), analysis of
variance (ANOVA) analysis was carried out as a regression analysis
using effect coding (Edwards, 1985; van Ginkel and Kroonenberg,
2014) so that results could then be combined according to Rubin’s
rules (van Ginkel and Kroonenberg, 2014). This approach has
the advantage of averaging over the results from different group-
ings determined using PSM on the multiply imputed datasets
(Hill, 2004). Guidelines and software for carrying out these
procedures and combining results for pooled estimates and statis-
tics are available here: http://www.socialsciences.leiden.edu/educ
ationandchildstudies/childandfamilystudies/organisation/staffcfs/
van-ginkel.html. One-tailed t-tests are reported given speciﬁc
directional hypotheses. Effect size measures (Cohen’s d) were also
determined and Cohen’s guidelines (Cohen, 1988) for interpret-
ing Cohen’s d’s (small, d = 0.2; medium, d = 0.5; large, d = 0.8)
were followed. Cohen’s d statistics were calculated using an online
calculator available here: http://www.uccs.edu/∼lbecker/
RESULTS
PARTICIPANT CHARACTERISTICS
Participant characteristics are reported in Table 1. No age or gen-
der differences were observed, however, all groups differed on
depression, anxiety and stress scales (Tukey’s HSD p < 0.05),
highlighting the need for PSM of patients in melancholia and
non-melancholia patient groupings.
HEART RATE AND ITS VARIABILITY
After application of PSM and pooling results according to
Rubin’s rules, groups differed signiﬁcantly on heart rate
[F(2,108.25) = 3.664, p = 0.029], RMSSD [F(2,107.86) = 3.21,
p = 0.044], HF (at trend levels) [F(2,102.76) = 2.966, p = 0.056],
and PCSD1 [F(2,107.87) = 3.199, p = 0.045; Figure 1]. No sig-
niﬁcant differences on the combined overall test were observed
for SDNN or LF. As hypothesized, heart rate was increased (by
7.85 beats per minute, BPM) in patients with melancholia –
but not in those with non-melancholia – relative to controls
(p = 0.004, one-tailed, d = 0.58). Also as hypothesized, HRV
was decreased in patients with melancholia – but not in those
with non-melancholia – relative to controls. More speciﬁcally,
RMSSD (p = 0.01, one-tailed, d = 0.56), HF (p = 0.014, one-
tailed, d = 0.57) and PCSD1 (p = 0.01, one-tailed, d = 0.56)
were all decreased in patients with melancholia, relative to
controls. No signiﬁcant differences were observed between non-
melancholia and controls. While patients with melancholia had
higher heart rate than those with non-melancholia (by 6.75 BPM;
p = 0.046, one-tailed, d = 0.20), no signiﬁcant differences
Table 1 | Participant characteristics: mean (M) ± standard error (SD).1
CTL (M ± SE) NMEL (M ± SE) MEL (M ± SE) p-value2
Age 35.69 ± 1.16 34.98 ± 1.56 37.28 ± 2.07 0.657
Gender 52F/42M 17F/15M 25F/15M 0.675
SIGH-D n/a 18.78 ± 0.68 21.50 ± 0.69 0.007
DASS-D 2.13 ± 0.25 21.70 ± 2.04 31.66 ± 1.39 <0.0013
DASS-A 1.19 ± 0.19 9.30 ± 1.79 15.23 ± 2.15 <0.0013
DASS-S 4.54 ± 0.47 19.00 ± 1.83 23.93 ± 1.88 <0.0013
CORE n/a 3.45 ± 0.53 7.18 ± 0.86 <0.0013
1M ± SE values based on original – not imputed data – data before propensity score matching of patient groupings; 2p-value refers to that for omnibus ANOVA, or for
SIGH-D and CORE, an independent-samples t-test; 3post hoc tests revealed that all groups differ from each other, Tukey’s HSD p < 0.05.
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FIGURE 1 | Means and standard error for participant groupings (controls, non-melancholia, melancholia) across each of the dependent measures
after controlling for age, gender, disorder severity, and comorbid anxiety disorders with propensity score matching.
on measures of HRV were observed between melancholia and
non-melancholia.
DISCUSSION
The current study examined the impact of melancholia and
non-melancholia on resting-state heart rate and HRV relative to
controls, revealing robust alterations in patients with melancho-
lia, but not in those with non-melancholia. These ﬁndings were
associated with a moderate effect size across multiple measures
(Cohens d’s = 0.56–0.58), providing strong evidence for an
impact of melancholia on vagally mediated, cardiac function.
We also observed patients with melancholia to display a higher
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heart rate, relative to those with non-melancholia. We and oth-
ers have demonstrated that HRV is inversely associated with
disorder severity (Kemp et al., 2010) and that antidepressant med-
ications – particularly tricyclic antidepressants and the serotonin
and noradrenaline reuptake inhibitors often used in more severe
depressions – have adverse effects on heart rate and HRV after
controlling for disorder severity (Licht et al., 2010; Kemp et al.,
2014). Together, these ﬁndings suggest that alterations in melan-
cholic patients with severe depression treated with antidepressant
medications would be stronger than those effects reported here, as
our patients were all unmedicated.
Here we show that resting-state heart rate is increased – by
almost eight beats per minute – and HRV, decreased in patients
with melancholia relative to healthy controls, ﬁndings associ-
ated with a moderate effect size. An increased resting-state heart
rate may reﬂect vagal withdrawal without necessarily, an increase
in sympathetic nervous system activity (Porges, 2011; Kemp
et al., 2014). This metabolically conservative response is usually
observed during environmental challenge. We have suggested
(Kemp et al., 2014) that this psychophysiological state may mir-
ror the autonomic dysregulation observed in psychiatric illness
during the resting-state, and the present study highlights that
this may be the case for those with melancholia in particular.
As noted above however, measures of HRV are more pure indi-
cators of vagal activity (Saul, 1990) than heart rate, which also
includes sympathetic input. Differences in heart rate were also
observed between those with melancholia and non-melancholia,
with those with melancholia displaying a higher heart rate, a
difference of 6.75 BPM, a ﬁnding associated with a small effect
size (Cohens d = 0.20). No differences however, were observed
on measures of HRV. We suggest that this ﬁnding may reﬂect
differences in a non-vagal (perhaps sympathetic) component of
cardiac function. It is possible therefore that while vagal function
distinguishes between patients and controls, non-vagal compo-
nents of heart rate may further distinguish between disorder
subtypes.
Critically, studies have reported strong evidence for a contin-
uous increase in risk for cardiovascular and all-cause mortality
in men and women with a resting heart rate above 60 beats/min,
regardless of whether individuals have a history of cardiovascu-
lar disease (Fox et al., 2007; see also Cooney et al., 2010; Saxena
et al., 2013). Here we observed patients with melancholia to dis-
play a higher resting, heart rate (78.48 BPM) relative to controls
(70.63 BPM) and thosewith non-melancholia (71.73 BPM).Other
studies (Lemogne et al., 2011; Åberg et al., 2014) have reported
a relationship between high heart rate and suicide. In fact, 10
additional beats per minute has been shown to increase risk of
suicide by 24 to 37% over a 9 year follow-up period in adjusted
models (Lemogne et al., 2011). Another study on more than 1-
million, 18-year-old participants with no prior mental illness
(Åberg et al., 2014) reported that poor performance on cardio-
vascular ﬁtness and cognitive tests was associated with a ﬁvefold
increased risk of suicide attempt or death over a 5- to 42-year
follow-up period.
In addition to increases in heart rate, we also observed decreases
in all measures of HRV except for SDNN and LF in patients with
melancholia relative to controls. While SDNN reﬂects the ‘ebb and
ﬂow’ of a variety of factors including respiration, blood pressure
control mechanisms, thermoregulation and kidney functioning,
RMSSD is a more speciﬁc index of vagal function that correlates
highly with the high-frequency component of HRV (Kleiger et al.,
2005). Recent thinking also indicates that the low-frequency com-
ponent of HRV reﬂects bloodpressure controlmechanisms such as
the baroreﬂex (Goldstein et al., 2011; Reyes Del Paso et al., 2013).
It is possible therefore that SDNN from short-term recordings is
less sensitive than that extracted from 24-h long recordings, and
that blood pressure control mechanisms are less involved in the
differences observed here between patients with melancholia and
controls.
A recent meta-analysis (Hillebrand et al., 2013) reported that
HRV can predict the ﬁrst cardiovascular event in individuals with-
out known cardiovascular disease over a period of 3.5 to 15 years.
Cardiovascular endpoints included hospitalization for angina pec-
toris, myocardial infarction, congestive heart failure, arterial
peripheral vascular disease, coronary revascularization, stroke and
cardiovascular death. This meta-analysis (Hillebrand et al., 2013)
was based on eight studies with a total of 21,988 participants with-
out known cardiovascular disease at baseline and reported pooled
relative risks for a ﬁrst cardiovascular event ranging from 1.35,
1.45, and 1.32 for SDNN, low-frequency or high-frequency HRV
measures respectively. The authors proposed two possible mech-
anisms for their ﬁndings including vagal dysregulation activating
inﬂammatory processes culminating in cardiovascular events. The
other suggested mechanism was that individuals with low HRV
already suffer from subclinical or silent CVD, highlighting that
reduced HRV may be both a cause and consequence of ill health.
Importantly, participants in the present study were free from seri-
ous medical conditions that may have otherwise impacted on the
ﬁndings reported here.
It is important to note that our ﬁndings were obtained after
accounting for a variety of confounding variables including
severity of depression, anxiety and stress, and number of comor-
bid anxiety disorders. No signiﬁcant differences were observed
between patients with non-melancholia and controls, suggest-
ing that heterogeneity in patient samples may underpin some
of the past null ﬁndings that have been reported in the liter-
ature. Strengths of the present study include a medication free
and physically healthy sample, and application of PSM to control
for a variety of confounding variables across patient groupings.
It is also important to acknowledge some limitations of our
study. There are potential confounding factors that we did not
control for here including physical activity (Rennie et al., 2003;
Soares-Miranda et al., 2014), smoking status (Sjoberg and Saint,
2011; Harte and Meston, 2014), alcohol use (Quintana et al.,
2013a,b), bodymass index (Britton et al., 2007; Koenig et al., 2014),
and biomarkers including fasting glucose (Stein et al., 2007) and
cholesterol (Britton et al., 2007; Thayer and Fischer, 2013), all of
which may impact on heart rate parameters. We refer interested
readers to a recent review of the various issues that researchers
should consider when collecting measures of HRV (Quintana and
Heathers, 2014). Regardless, we note here that many of these
factors known to impact onheart rate parameters are also observed
in patients with mood disorders, highlighting the importance of
cardiovascular risk reduction strategies in such patients, and on
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the basis of the present study, those with melancholic symptoms
in particular.
In conclusion, we report here that patients with melancho-
lia – but not non-melancholia – display robust reductions in
resting-state HRV relative to controls. This ﬁnding was observed
even when applying PSM, a relatively novel technique to ensure
that patient groupings did not differ on important confounds
including age, gender, severity of depression, anxiety and stress,
and comorbid anxiety disorders. Reduced vagal tone has impor-
tant functional signiﬁcance (e.g., impaired psychological ﬂexi-
bility; Thayer and Lane, 2000; Kashdan and Rottenberg, 2010),
and over the longer-term may lead to signiﬁcant morbidity
and mortality from a host of conditions (Thayer et al., 2010;
Kemp and Quintana, 2013). Our study therefore, has impor-
tant implications for the health and wellbeing of patients with
melancholic depression. Future studies are needed to further
examine what particular behavioral features are most associ-
ated with the alterations in heart rate and HRV in patients with
melancholia.
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